These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22236542)

  • 1. Expression of caveolin-1, caveolin-2 and caveolin-3 in thyroid cancer and stroma.
    Kim D; Kim H; Koo JS
    Pathobiology; 2012; 79(1):1-10. PubMed ID: 22236542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma.
    Koo JS; Shin E; Hong SW
    APMIS; 2010 Oct; 118(10):744-52. PubMed ID: 20854468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status.
    Paskaš S; Janković J; Marečko I; Išić Denčić T; Tatić S; Cvejić D; Savin S
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):201-9. PubMed ID: 24255086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
    Liu Z; Kakudo K; Bai Y; Li Y; Ozaki T; Miyauchi A; Taniguchi E; Mori I
    J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between activated STAT3 protein and epithelial-mesenchymal transition in papillary thyroid carcinoma].
    Zhang Z; Bai Y; Li P; Zhao J; Wang Y; Sun L; Tang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(22):1265-8. PubMed ID: 24616987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.
    Jung CW; Han KH; Seol H; Park S; Koh JS; Lee SS; Kim MJ; Choi IJ; Myung JK
    Int J Clin Exp Pathol; 2015; 8(1):560-8. PubMed ID: 25755746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young.
    Koo JS; Hong S; Park CS
    Thyroid; 2009 Nov; 19(11):1225-31. PubMed ID: 19888860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
    Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
    Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An immunohistochemical study of CTHRC1,Vimentin,E-cadherin expression in papillary thyroid carcinoma].
    Tang ZN; Wang YC; Liu XX; Liu QL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 32(8):595-598. PubMed ID: 29798143
    [No Abstract]   [Full Text] [Related]  

  • 10. Diffuse sclerosing variant of papillary carcinoma of the thyroid: ultrasound features with histopathological correlation.
    Kwak JY; Kim EK; Hong SW; Oh KK; Kim MJ; Park CS; Cheong WY
    Clin Radiol; 2007 Apr; 62(4):382-6. PubMed ID: 17331834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
    Lin Y; Ma Q; Li L; Wang H
    Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].
    Cui XJ; Zhao HO; Su P; Chen J; Zhang RY; Pan Y; Ouyang XM; Liu J; Zhang JQ; Yang Y; Yang R; Ding L; Liu ZY
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):354-359. PubMed ID: 29783802
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype.
    Sun WY; Kim HM; Jung WH; Koo JS
    J Transl Med; 2016 Jun; 14(1):168. PubMed ID: 27277113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary thyroid carcinoma with nodular fasciitis-like stroma: a usual entity with distinctive morphology.
    Ginter PS; Scognamiglio T
    Int J Surg Pathol; 2015 Jun; 23(4):305-7. PubMed ID: 25663334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.
    Cho SW; Kim YA; Sun HJ; Ahn HY; Lee EK; Yi KH; Oh BC; Park DJ; Cho BY; Park YJ
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1641-9. PubMed ID: 24848709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway.
    Cui D; Zhao Y; Xu J
    Biochimie; 2018 May; 148():1-11. PubMed ID: 29471001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin].
    Liu C; Chen X; Gao Z; Liu Z; Tao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(17):789-91, 795. PubMed ID: 23214316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
    Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
    Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.